Objective: This study aimed to investigate the influence of early-onset type 2 diabetes on the risk of developing diabetic retinopathy (DR), referable diabetic retinopathy (referable DR), and sight-threatening diabetic retinopathy (STDR).

Method: A total of 6847 individuals with type 2 diabetes were included. Individuals diagnosed with type 2 diabetes at or before the age of 40 are defined as having early-onset T2DM. Logistic regression and interaction analysis were used to assess the risk of DR, referable DR, and STDR in early versus late-onset diabetes. Kaplan-Meier analysis and cox regression analysis were employed to measure the relationship between incidences of retinopathy and early-onset diabetes in 1507 patients without DR at baseline.

Results: The early-onset group exhibited a higher prevalence of any DR, referable DR, and STDR with a diabetic duration exceeding 5 years (all P<0.05).After adjusting for confounding factors, early-onset diabetes showed a significant association with an increased risk of referable DR and STDR (P=0.02 and P=0.03, respectively), with an interaction based on diabetes duration (P for interaction = 0.01 and P for interaction = 0.02 respectively).In follow-up analysis, the early-onset group had a significantly higher cumulative incidence of referable DR in terms of diabetes duration compared to the late-onset group (12.21% vs 9.8%, P=0.03).The multivariable-adjusted hazard ratios for referable DR in early-onset diabetes were 3.25 (95% CI 1.11-9.47) relative to the late-onset group, only in patients with a duration over 10 years.

Conclusions: Early-onset diabetes increased the risk of referable and sight-threatening DR, especially in those with diabetes duration over 10 years. Enhanced retinal screening and comprehensive diabetes manangement are vital for individuals with early-onset diabetes.

Disclosure

C. Meng: None. Y. Ma: None. Y. Wang: None.

Funding

National Key Research and Development Program of China (2021YFC2501600, 2021YFC2501601)

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.